Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onradivir vs Oseltamivir in Acute Uncomplicated Influenza A
NCT04683406Phase 3Completed
- Sponsor
- Raynovent Biotech
- Start
- Dec 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anlatrelvir in Influenza A (IAV), sponsored by Raynovent Biotech. Started Dec 2020; status: completed.
02
Drugs
anlatrelvir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT04683406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683406.